Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.

Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.

Item
http://www.wikidata.org/entity/Q34091615
Nutrition and cancer: a review of the evidence for an anti-cancer dietUpdate on the challenges and recent advances in cancer immunotherapyPriming with very low-affinity peptide ligands gives rise to CD8(+) T-cell effectors with enhanced function but with greater susceptibility to transforming growth factor (TGF)β-mediated suppression.LC-MS/MS Identification of a Bromelain Peptide Biomarker from Ananas comosus MerrAcute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasmaExogenous proteases confer a significant chemopreventive effect in experimental tumor models.Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.Antiangiogenesis, loss of cell adhesion and apoptosis are involved in the antitumoral activity of Proteases from V. cundinamarcensis (C. candamarcensis) in murine melanoma B16F1.Anti-inflammatory and immunomodulatory properties of Carica papaya.Bromelain down-regulates myofibroblast differentiation in an in vitro wound healing assay.Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14.Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain.Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.Comparison of effectiveness of abrasive and enzymatic action of whitening toothpastes in removal of extrinsic stains - a clinical trialCysteine Proteases from () Inhibit Melanoma Metastasis and Modulate Expression of Proteins Related to Proliferation, Migration and Differentiation
P2860

Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.

Item
http://www.wikidata.org/entity/Q34091615
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@ast
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@en
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@nl
type
label
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@ast
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@en
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@nl
prefLabel
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@ast
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@en
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood.
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
Oral therapy with proteolytic enzymes decreases excessive TGF-beta levels in human blood
@en
P2093
P2888
P304
P31
P356
P478
P50
P577
P5875
P6179
P698
P921